All bites
Pre-SeedHealthtech·BackgroundSignal 34 · US market

Siggy raises $6M Pre-Seed

Company
Siggy
Funding stage
Pre-Seed
Amount
$6M
Date
Location
🇺🇸 the US
Sector
Mental Health
Investors
Undisclosed

What happened

Mental health startup Siggy has raised $6 million in pre-seed funding. The company is developing an AI-powered service to collect patient histories and track progress between clinician visits.

Why it matters

Clinical workflow AI in healthtech continues to command outsized initial round sizes when targeting clinician burden.

What to watch

Clinical adoption speed and patient retention across therapy practices testing the platform.

VCBites Signal

34/ 100
Background signal

Why this score: A $6M pre-seed round is high for early-stage healthtech, reflecting interest in automated patient data collection.

VCBites' internal significance rating (0-100) — our editorial read, not a market-standard metric. VC Bites' assessment of the significance of this development to the venture ecosystem. Not investment advice.

Who should care?

  • Healthtech Founders
  • Seed Investors
  • AI Founders

Source

This is an original short summary. Read the full reporting at the original source.

Read the original story on Crunchbase News

Share the signal

VC Bites

Siggy raises $6M Pre-Seed

VCBITES SIGNAL: 34 / 100

Why it matters

Clinical workflow AI in healthtech continues to command outsized initial round sizes when targeting clinician burden.

VC Bites · Venture capital signals, explained.

The post text is copied to your clipboard so you can paste it alongside the link.

More Healthtech bites

UndisclosedHealthtechCanada·BackgroundSignal 32 · Canada market

Specific Biologics raises $35M

Toronto-based Specific Biologics, a Western University spinout, raised $35 million to advance its gene-editing therapy for ALS. The funding follows promising pre-clinical results.

Why it matters

Pre-clinical university spinouts securing mid-eight-figure rounds demonstrate ongoing capital commitment to deep-tech therapeutics targeting severe neurodegenerative diseases like ALS. Securing $35 million provides the runway necessary to transition proprietary platform assets into initial human clinical trials.

What to watch

Regulatory submissions and timeline milestones for advancing the ALS gene-editing therapeutic into Phase 1 clinical trials.

UndisclosedHealthtechCanada·BackgroundSignal 35 · Canada market

DropGenie raises $5M USD

Biotech startup DropGenie has secured $5 million USD in funding with backing from BDC. The company operates in Montréal and Boston to accelerate biological data extraction.

Why it matters

Operating across Montréal and Boston enables DropGenie to bridge Canadian research capabilities with established US biopharma networks.

What to watch

Scaling of biological data extraction capabilities and expansion into US commercial partnerships.

UndisclosedHealthtech·NotableSignal 44

Even Healthcare reaches $300M valuation in Khosla Ventures-led round

Even Healthcare reached a $300 million valuation in a new financing round led by Khosla Ventures. The company intends to use the capital to expand its hospital network in India.

Why it matters

Khosla Ventures' backing of Even Healthcare at a $300 million valuation signals sustained tier-1 US investor appetite for tech-enabled physical healthcare networks in India. Blending digital management with physical hospital infrastructure represents a capital-intensive evolution of standard healthtech delivery in emerging markets.

What to watch

Whether healthtech operators expanding into physical hospital footprints can sustain software-like margins while managing heavy capital expenditures.